| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |